Skip to main content
  • Systematic Review
  • Open access
  • Published:

The Use of Biofluid Markers to Evaluate the Consequences of Sport-Related Subconcussive Head Impact Exposure: A Scoping Review



Amidst growing concern about the safety of sport-related repetitive subconcussive head impacts (RSHI), biofluid markers may provide sensitive, informative, and practical assessment of the effects of RSHI exposure.


This scoping review aimed to systematically examine the extent, nature, and quality of available evidence from studies investigating the effects of RSHI on biofluid markers, to identify gaps and to formulate guidelines to inform future research.


PRISMA extension for Scoping Reviews guidelines were adhered to. The protocol was pre-registered through publication. MEDLINE, Scopus, SPORTDiscus, CINAHL, PsycINFO, Cochrane Library, OpenGrey, and two clinical trial registries were searched (until March 30, 2022) using descriptors for subconcussive head impacts, biomarkers, and contact sports. Included studies were assessed for risk of bias and quality.


Seventy-nine research publications were included in the review. Forty-nine studies assessed the acute effects, 23 semi-acute and 26 long-term effects of RSHI exposure. The most studied sports were American football, boxing, and soccer, and the most investigated markers were (in descending order): S100 calcium-binding protein beta (S100B), tau, neurofilament light (NfL), glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), brain-derived neurotrophic factor (BDNF), phosphorylated tau (p-tau), ubiquitin C-terminal hydrolase L1 (UCH-L1), and hormones. High or moderate bias was found in most studies, and marker-specific conclusions were subject to heterogeneous and limited evidence. Although the evidence is weak, some biofluid markers—such as NfL—appeared to show promise. More markedly, S100B was found to be problematic when evaluating the effects of RSHI in sport.


Considering the limitations of the evidence base revealed by this first review dedicated to systematically scoping the evidence of biofluid marker levels following RSHI exposure, the field is evidently still in its infancy. As a result, any recommendation and application is premature. Although some markers show promise for the assessment of brain health following RSHI exposure, future large standardized and better-controlled studies are needed to determine biofluid markers’ utility.

Key Points

  • This is the first systematically conducted review focused on scoping biofluid markers in sport-related repetitive subconcussive head impact (RSHI) research, identifying a significant body of evidence not previously featured in relevant systematic reviews.

  • The scoping review identified critical limitations of the current research in the field, including lack of impact monitoring and failure to sufficiently control for confounding variables such as concussion history and the effect of exercise. Findings reveal that the current evidence base is largely heterogeneous, limiting any firm conclusions at this stage.

  • Despite limited and heterogeneous evidence, some markers appeared to show promise in detecting the effects of subconcussive head impacts.


A growing body of evidence demonstrates a link between participation in sports that have a high incidence of (head) impacts and long-term neurological impairment and/or neurodegenerative diseases [1,2,3,4,5,6,7,8,9]. It is thought that as many as 10–20% of professional boxers suffer from chronic neuropsychiatric disorders [10,11,12]. Furthermore, an increased incidence of neurodegenerative diseases has been observed in ex-professional soccer [2, 7], rugby [9], and National Football League players [8] compared to the general population. Traumatic brain injury (TBI) is increasingly recognized as a risk factor for later developing neurodegenerative processes and diseases [6, 13, 14]. Evidence for a link between contact sport and chronic traumatic encephalopathy (CTE) is also strengthening [1, 15, 16]. Interestingly, years of contact sport exposure has been associated with CTE pathology regardless of the number of symptomatic TBIs such as sport-concussion [15]. In fact, estimated total cumulative exposure to repetitive head impacts has been found to be a stronger predictor of later cognitive and neurobehavioral impairment than concussion history in American football players [17]. The recently emerging picture is that routine exposure to repetitive head impacts may pose a significant risk to brain health, quite separate from (accidental) impact exposure resulting in TBI (e.g., sport-concussion). Routine impacts in sport are either direct hits to the head (such as soccer headers) or blows to the body (e.g., full-body collisions between players, which are frequent in sports such as rugby, ice hockey, and American football). In recent years, a prominent public debate has started regarding the safety of routine head impacts in contact sports [18]. Such impacts are termed repetitive subconcussive head impacts (RSHI) and characterize the routine and repeated head impacts athletes sustain during contact sport participation that do not result in overt concussion symptoms [19]. Different lines of enquiry are based on the idea that RSHI can trigger subclinical pathology and a complex cascade of molecular alterations [20].

There are two main reasons why the relationship between RSHI and pathological processes has been seemingly neglected until recently. One is that TBI, such as sport-concussion, is common in those sports that also expose participants to RSHI, meaning that the two sources of impact in sport are often conflated (a study challenge addressed in this review). Inevitably, the symptomatic source of impact (concussion) receives more attention with regard to consequences to brain health than the routine and ‘normalized’ source of impact that does not result in evident injury symptoms. The latter issue, lack of evident symptoms, is also the second main reason why RSHI may be under-researched. Until recently, measures to assess brain health consequences of RSHI appeared to lack sensitivity [18]. While it is unclear what risk RSHI poses to brain health, there is a need for measures that are (1) sensitive, (2) specific, and (3) informative in revealing the effects of RSHI on the brain. Biofluid markers of brain injury have developed in recent years, and their use to detect RSHI-induced brain changes is an emerging field of research [21, 22]. Biofluid markers of brain injury can potentially be an efficient and practical method for providing information about routine sport-related RSHI exposure effects on brain health.

Multiple international studies have provided evidence that biofluid markers are associated with brain damage after TBI and have the potential as an objective tool for diagnosis and outcome prediction [23,24,25,26,27,28]. The implementation of ultrasensitive assays has opened up possibilities to accurately and noninvasively detect subtle structural damage, and more recently, it has been shown that biomarkers can also be used to monitor progressive alterations in the brain, years after TBI [29]. Furthermore, biomarker levels indicate axonal, neuronal and astroglial changes and injury, and their combination can reflect (and provide information on) molecular and cellular responses and underlying pathological mechanisms triggered by head trauma [30,31,32]. As such, there is evident potential for the use of biomarkers to identify subtle RSHI-induced brain changes that may be undetectable based on clinical criteria or imaging assessment. Assessing the functionality of different biomarkers and their ability to detect the effects of RSHI on the brain is thus of great importance: these markers may aid understanding of RSHI-induced brain pathology and give an insight into the link between acute brain changes and chronic neurodegenerative sequelae. The biofluid marker evidence base specific to the effects of RSHI has, however, not yet been reviewed. The evaluation of the biomarkers in RSHI is complicated by methodological and analytical variability among studies, including research designs, populations, settings, sampling times, analytical approaches, sources, and outcomes being assessed.

Therefore, we conducted a scoping review to identify and comprehensively map the number, features, and quality of studies that have explored the effects of RSHI on biomarker levels. Besides providing an overview of the existing and emerging evidence, we focused on defining methodological problems and identifying potential solutions and research gaps to inform and guide the design and analysis of future studies and research.


Protocol and Registration

This scoping review adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) [33] guidelines. The review protocol has been published in BMJ Open [19].

Information Sources

The following seven electronic databases were searched from inception until March 2022: Cochrane Library, MEDLINE (EBSCO host), Scopus, SPORTDiscus, CINAHL Complete, PsycINFO, and OpenGrey. The following clinical trial registration platforms were also searched for relevant protocols and corresponding full-text publications: and WHO International Clinical Trials Registry Platform. Key descriptors that included terms for subconcussive head impacts, biomarker, and contact sport (see Additional file 1: Table S1 for examples) were used for the search. The full search strategies are available in Additional file 1: Table S1. Reference lists of the included studies were also screened to identify additional records.

Study Selection and Eligibility Criteria

We used the web-based systematic review software Covidence (Covidence, Veritas Health Innovation, Melbourne, Australia) (available at for the selection process. After the removal of duplicates, two reviewers (L-ML and MN) independently screened the titles and abstracts against the predetermined eligibility criteria, followed by full-text review of retained articles. Any disputes between reviewers were resolved through discussion and if necessary, by a third reviewer (SM).

We included studies that investigated biofluid markers, including brain injury markers such as S100 calcium-binding protein beta (S100B), ubiquitin C-terminal hydrolase L1 (UCH-L1), glial fibrillary acidic protein (GFAP), neurofilament light (NfL), tau, and microRNAs (miRNAs), cytokines, chemokines, and hormones, in blood (serum or plasma), cerebrospinal fluid (CSF), saliva or urine in athletes who were acutely or chronically exposed to sport-related RSHI. We excluded studies assessing biomarker concentrations following solely sports-related concussion or traumatic brain injury. Studies that assessed the effects of repetitive head impacts (both RSHI and concussions) were included. However, if those studies did not separate concussions from RSHI through either (1) exclusion of concussion cases or (2) analysis (covariate), then this was reflected in the bias and quality rating conducted as part of this review. Post-mortem and non-human examinations were also excluded. No restrictions were placed on methodological standards, analytical platforms, study design, and sample size. Studies were included regardless of geographic location and date of publication. We considered reports in the English, French, German, and Italian languages. Detailed inclusion criteria including the Population, Exposure, Comparator, Outcomes, and Study Design (PECOS) framework applied in this scoping review are available in Additional file 1: Table S2. A list of excluded articles with reasons for exclusion (e.g., duplication or redundant publication) during full-text screening is provided in Additional file 1(Table S3).

Data Extraction and Results Categorization

Data were recorded independently by two reviewers using a standardized and piloted data collection form. Disagreements were discussed until consensus was reached, and, if necessary, a third reviewer was consulted for arbitration. Information about the study design, aim(s), population, RSHI definition, exposure to RSHI, and biofluid marker characteristics (including sampling time, source, analytical platform, and concentrations) were extracted. Studies were classified as either laboratory- or field-based, depending on whether the RSHI occurred in a controlled environment or in the field (such as during training, games, or matches). Further, studies were categorized as acute, semi-acute, or chronic. Studies were considered acute if changes in biomarker concentrations were assessed immediately following RSHI exposure (< 2 weeks) and semi-acute if changes were assessed following an extended rest period from RSHI (e.g., ≥ 2 weeks), or if the effects of accumulation of RSHI were assessed over a season. Studies that investigated the relationship between the history of contact sport participation (years of participation, total number of games or competitions in lifetime) and biofluid marker concentrations were considered to assess the chronic effects.

Risk of Bias and Quality Assessment of Included Studies

A modified version of the risk of bias in non-randomized studies of interventions (ROBINS-I) tool [34] was used to assess the methodological quality of all primary research publications by evaluating four domains: (1) confounding variables, (2) missing data, (3) measurement of outcomes, and (4) selection of reported results. Confounding variables were considered factors, other than RSHI, that could influence the concentration of the biofluid markers, such as exercise, history of concussion, peripheral injuries, neurological diseases, and so on.

In addition, to increase rigor and determine the quality of study reporting, a modified version of the Subconcussion-Specific Tool (SST) was utilized to assess the quality of the included studies [22, 35]. Each study was assessed for the following six criteria: (1) Was there an attempt to define the term ‘subconcussion’? (2) Was the number or magnitude of impacts reported (or used in the analysis)? (3) Were participants who sustained a concussion during the study controlled for or excluded from analyses? (4) Were participants with a history of concussion controlled for or excluded from the analyses? (5) Was the control group matched on two or more variables (e.g., history of concussion, sex, age, etc.)? (6) Did the study analyze sex differences, or acknowledge limitations associated with sampling only males or females? Studies were classified as category A, B, or C (i.e., high, medium, and low quality) depending on how many criteria were fulfilled. Category A studies met five or more criteria, B category studies three or four criteria, and C two or less. Question three was not relevant to cross-sectional studies assessing the chronic effects of RSHI in retired athletes and as such, for the purpose of classification, this criterion was considered achieved for these studies. Two of the review authors (L-ML, MN) independently assessed the studies for the risk of bias and quality. Disagreements were resolved through consensus and if necessary, arbitration by a third reviewer was sought.

Synthesis and Reporting of the Results

The search results are reported in a flow diagram detailing the review decision process. The synthesis of results includes a narrative and quantitative summary in text and the main characteristics of the included studies are presented in tables. The results are categorized and presented according to a priori defined categories and inductively developed categories (i.e., biofluid markers, the timing of sampling [acute, semi-acute or chronic], setting [laboratory or field], and sample source [blood, CSF or saliva]). Risk of bias graphs were generated using robvis web-based software [36] (available at


Description of Studies

Our searches retrieved 7062 records from which 4135 titles and abstracts were screened following the removal of duplicates. One hundred and thirty-five full-text articles were assessed for eligibility and 79 articles were included in the review (see Fig. 1; detailed information about the studies can be found in Additional file 1: Table S4). Inter-rater reliability in the study identification process was substantial for title/abstract screening and moderate for full-text review (κ = 0.71 and 0.60, respectively).

Fig. 1
figure 1

PRISMA flow diagram

The earliest identified record was published in 1982 [37] with the number of studies increasing remarkably in the last decade (Fig. 2).

Fig. 2
figure 2

a Temporal trend of all the studies; b Temporal trend by biomarker

The majority (~ 85%) of the studies employed an observational design with 44 cohort, 19 cross-sectional, and four case–control studies. Only 11 studies (~ 14%) employed an experimental design with seven of them being randomized. We identified just one case report relevant to this scoping review.

Forty-nine studies assessed markers acutely, 23 in the semi-acute-phase and 26 investigated long-term effects. Eighteen studies assessed a mix of the acute, semi-acute, or chronic effects of RSHI exposure.

Further, 13 studies (~ 16%) were laboratory-based and 45 were field-based (~ 57%). A case report and the majority of the chronic studies were not considered laboratory- or field-based and were categorized as ‘other’ (22 out of 79, ~ 28% of studies).

Most studies (~ 53%) have been conducted on male athletes (42 out of 79). There were only two studies conducted on female participants [38, 39] and 20 included a mixed population. Sex was not specified in 15 studies. Only three studies included exclusively individuals younger than 18 years (age range ~ 13–17) [40,41,42]. Fifty-two studies employed either a control condition or had a control cohort.

Most studied markers were: S100B (30 studies), tau (24 studies, including 4 studies assessing tau in extracellular vesicles [EVs]), NfL (20 studies), GFAP (14 studies), NSE (9 studies), BDNF (7 studies), phosphorylated tau (p-tau) (7 studies), and UCH-L1 (6 studies) (see Table 1). Further, nine studies assessed the hormonal response to RSHI (~ 10%). All other biofluid markers had fewer than five research publications available per marker; information about all markers is provided in Additional file 1: Table S4. The vast majority of the samples were venous i.e. from serum and/or plasma (72 studies), while some studies sampled from cerebrospinal fluid (six studies) [4348], or from saliva (five studies) [4953].

Table 1 Biomarker specific tables for selected biomarkers: S100B, tau, neurofilament light (NfL), glial fibrillary acidic protein (GFAP), neuron-specific enolase (NSE), brain-derived neurotrophic factor (BDNF), and ubiquitin C-terminal hydrolase—L1 (UCH-L1)

American football was the most studied sport with 26 studies, followed by soccer with 21, and boxing with 18 (including 2 kickboxing) studies (Fig. 3).

Fig. 3
figure 3

Number of articles per sport (MMA—mixed martial arts)

Fifteen research reports (~ 19%) provided a definition for subconcussive head impacts (definitions provided in Additional file 1: Table S5). Forty-seven studies (~ 60%) quantified or estimated RSHI exposure. Of the acute and semi-acute studies, 12 employed the use of accelerometers to document impact (see Additional file 1: Table S6 for impact information). Five of the 12 studies assessed impact data from soccer heading and six studies assessed RSHI metrics in American football. Where reported, peak average (or median) linear acceleration per impact ranged from 13.3 to 114.7 g.

Thirty (~ 38%) of the studies included an additional outcome measure other than biofluid marker(s) to assess the effects of RSHI. Commonly used measures included brain imaging (in 9 studies) and neurocognitive tests, motor control, and/or concussion symptom assessment (in 26 studies); five studies had a multimodal approach integrating brain imaging and neurocognitive tests, motor control, and/or concussion symptom assessment.

Methodological Quality of Evidence

Based on our analysis of the risk of bias, two studies (~ 2.5%) were scored as critical, 20 (~ 25%) as serious, 49 (~ 62%) as moderate, and only 8 (~ 10%) of the studies received a low risk of bias rating. Most studies that received moderate or higher risk of bias did so due to failing to control for confounding variables (Fig. 4). The findings of all identified studies are considered in this review to fully scope the body of evidence.

Fig. 4
figure 4

a Review authors’ rating for individual risk of bias domains and the overall score for each study; b An applicability concerns graph summarizing the pooled risk of bias score for each domain as a percentage. D1: Bias due to confounding; D2: Bias due to missing data; D3: Bias in measurement of outcomes; D4: Bias in selection of the reported results; D5: Overall bias result

Specific subconcussion methodological quality assessment results are displayed in Table 2; ~ 46% of studies received a category C (n = 36), ~ 40.5% category B (n = 32), and ~ 14% category A (n = 11) rating meeting almost all of the criteria with regard to subconcussion methodological quality. The most common unmet criteria were a failure to provide a definition for RSHI or account for sex differences.

Table 2 Quality assessment outcomes for individual studies using a modified version of the Subconcussion-Specific Tool

Summaries for the Most Studied Biofluid Markers

S100 Calcium-Binding Protein beta (S100B)

Glial injury marker S100B was the most examined protein with 30 studies (Table 1), with a median study sample size of 29 (range 8 to 415) contact sport athletes. Twenty-four studies assessed the acute effects of RSHI on S100B concentrations in blood [38, 40, 41, 48, 54, 56, 58,59,60,61,62, 64,65,66,67,68,69,70,71,72,73,74,75,76], of which 17 studies found a significant increase in S100B within two hours of RSHI exposure [38, 41, 54, 56, 59, 60, 64, 65, 67,68,69,70,71,72, 74,75,76] (range 1.3–5.3-fold, 26%-431% increase). All 17 studies were field-based, where the effect of physical activity could not be eliminated. Eight of the 17 studies employed a control group or condition investigating the effect of exercise and/or peripheral injuries on S100B levels [59, 60, 64, 67, 69, 72, 74, 76]. Critically, in six of the eight studies, a significant increase in S100B was observed also in the control group or control condition [64, 67, 69, 72, 74, 76]. Overall, S100B increased 1.3–1.8-fold (26–78% increase) following exercise alone [67, 72, 76]. Laboratory-based studies investigating the effects of soccer heading, where physical activity was controlled, reported no effect of RSHI on S100B [40, 48, 58, 69, 73, 118].

Increases in S100B were found to be significantly correlated with impact metrics, with studies reporting correlation coefficients ranging from 0.43 to 0.66. However, one study reported a correlation between increases in S100B and the number of jumps in a basketball game (r = 0.71) [74].

Two studies measured S100B in CSF following exposure to RSHI. One study reported significantly (1.2-fold) higher S100B concentrations in CSF (but not in serum) 1–6 days after a boxing bout compared to the controls [46, 66]. In the other study, S100B levels in CSF and serum were not significantly higher compared to the control group 7–10 days after controlled soccer heading [48]. Overall, S100B appears to increase following RSHI only if accompanied by physical exertion and the marker is sensitive to the effect of exercise regardless of head impacts.

None of the nine studies that assessed the semi-acute effects of RSHI found a significant increase in S100B [41, 46, 52, 63, 65,66,67,68, 72]. Also, no relationship between prior contact sport exposure and S100B was found in the three studies that investigated the chronic effects of RSHI in active contact sport athletes following a period of rest (2–6 months) from contact sport participation [55, 77, 80]. Overall, semi-acute and chronic RSHI exposure does not appear to cause elevations in S100B levels.


Twenty-four studies examining the effects of RSHI on tau were identified (all 24 studies assessed total tau levels), with a median study sample size of 32 (range 8 to 415) contact sport athletes. Information about study type and design, type of exposure, and participant characteristics can be found in Table 1. Of these, 11 studies examined the acute effects of RSHI on tau concentrations; six studies had a moderate or low risk of bias, four of which reported significant tau increases after impacts incurred in boxing [46, 47] and American football [42, 81], the other two did not report significant findings after soccer heading [85] and an American football match [61]. Eight studies investigated the semi-acute effects of RSHI yielding mixed findings. Four of the studies found no significant differences in tau concentrations [46, 66, 86, 119], while two found significant increases [42, 79] (albeit one of these studies found yearly increases only in active mixed martial arts fighters but not in boxers [79]) and another a significant decrease [87] (one study failed to detect tau in serum [52]). Twelve of the 24 studies examined if RSHI causes chronic tau increases, of which six did not find significant differences [44, 47, 55, 79, 83, 88], while four studies found increased tau levels [53, 80, 84, 89]. Furthermore, two studies found a correlation between RSHI career exposure and tau concentrations, although the concentrations were not significantly different to those of controls [43, 78]. Therefore, although tau is one of the markers currently receiving the most attention (see Fig. 2), its utility in evidencing the effects of RSHI in contact sport is uncertain.

Seven of the aforementioned 24 studies also examined phosphorylated tau (p-tau). Two investigated the acute effects of RSHI on p-tau, finding no significant differences [46, 47]. One study [46] also investigated the semi-acute effects, again reporting no significant results. The chronic sequelae of RSHI on p-tau concentrations in active and former athletes were investigated in six studies, with four of them reporting no significant effects in American [43, 44] and Australian Rules football players [83], or boxers [47], while two studies reported significant 1.2–1.8-fold increases in former and active American football players [53, 84]. All seven studies had a moderate risk of bias. Overall, the utility of p-tau in evidencing the effects of RSHI in contact sports is uncertain.

Neurofilament Light (NfL)

Twenty studies examining the effects of RSHI on NfL concentrations were identified, with a median study sample size of 32 (range 8 to 338) contact sport athletes. Information about study type and design, type of exposure, and participant characteristics can be found in Table 1. Twelve studies investigated the acute effects of RSHI on NfL concentration, with eight of them reporting a significant increase (boxing n = 4, soccer heading n = 3, American football n = 1) [46, 47, 79, 85, 90, 94,95,96]. NfL levels increased ~ 1.2–1.9-fold when sampled from serum compared to baseline levels or controls [79, 85, 90, 95, 96] and 4.1-fold in CSF [47]. The earliest increase was observed ~ 1 h post-RSHI exposure [90, 94], with the majority of the studies finding a significant increase at ≥ 24 h [46, 47, 79, 85, 95, 96]. Two of the eight studies sampled NfL from CSF [46, 47], with one study demonstrating that increases in CSF NfL concentration were positively correlated with serum NfL levels [47, 95]. Five of the acute studies also suggested a dose–response relationship between impact exposure (severity and/or quantity) and NfL levels [46, 47, 79, 94, 95]. Five of the seven studies identified as having a low or moderate risk of bias reported significant effects. NfL levels were not detectable in one of the 12 studies [48].

Significant increases were also reported in five of the eight studies that examined the semi-acute effects of RSHI in American football [87, 92, 93], boxing [46], and ice hockey [82]. Seven studies investigated whether chronic RSHI exposure results in elevated NfL levels, with three of them reporting significantly higher NfL levels than in controls (~ 2 times higher) [39, 47, 95]. However, none of the three studies investigated the relationship between lifetime exposure to RSHI and NfL levels, and all three studies were conducted in active contact sport athletes. Therefore, of the ‘up-and-coming’ biomarkers (see Fig. 2), NfL appears as one of the most promising in demonstrating the effects of RSHI on the brain, irrespective of the sport.

Glial Fibrillary Acidic Protein (GFAP)

Fourteen studies assessing the effects of RSHI on GFAP were identified with a median study sample size of 30 (range 8 to 415) contact sport athletes (see Table 1 for details on study type and design, type of exposure, and participant characteristics). Eight studies investigated the acute effects [42, 46,47,48, 61, 66, 68, 85] (three in CSF [46,47,48]), of which three studies found significant increases (1.3-2-fold) in GFAP levels following a boxing bout (in CSF) [46, 47] and soccer heading (in plasma) [85]. GFAP was not detectable (in serum/plasma) in two of the studies [66, 68].

Six studies assessed the semi-acute effects of RSHI by measuring GFAP concentrations [42, 46, 52, 66, 68, 82] (one in CSF [46]), with only one study reporting a significant increase [52]. All five chronic studies (carried out in active athletes) found no effect of RSHI on GFAP levels [47, 55, 57, 77, 83]. GFAP was not detectable (in serum/plasma) in three studies: two assessing semi-acute [66, 68] and one assessing chronic effects [77].

With regard to methodological constraints, the limits of detection for the assays failing to detect GFAP levels were 150 and 780 ng/L. Overall, GFAP appears not to be affected by RSHI; however, this conclusion is subject to limited evidence.

Neuron-Specific Enolase (NSE)

Nine studies investigating the effects of RSHI on NSE concentrations were identified, with a median study sample size of 26 (range 8–44) contact sport athletes (Table 1). Seven studies assessed the acute effects, of which all studies with moderate risk of bias (n = 6) reported significant findings, with soccer games causing a 1.1-2-fold increase in NSE [38, 75], American football a 1.9-fold increase [71], and boxing a 1.6–2.5-fold increase [59, 97]. The two studies examining the chronic effects yielded mixed results [77, 80]. Therefore, higher quality studies including NSE to examine the effects of RSHI showed promise, demonstrating the acute effects of head impact in sport.

Brain-Derived Neurotrophic Factor (BDNF)

Seven studies assessing the effects of RSHI on BDNF were found, with a median study sample size of 30 (range 15 to 44) contact sport athletes (Table 1). The acute effects were assessed in five studies, yielding mixed results [61, 66, 68, 98, 99]. BDNF was found to increase after boxing and taekwondo training [99] and an American football game [61], but not after a rugby match [68], in studies with a moderate risk of bias. The two studies that were identified as having a serious risk of bias showed increased BDNF after soccer heading [98] but no effects after a boxing bout [66]. Two studies investigated the semi-acute effects [66, 68], with one revealing increased BDNF concentrations after a rugby season [68], and two studies investigated the chronic effects without finding evidence of BDNF alterations [77, 80]. Therefore, BDNF as a measure appears to reveal little about the effect of RSHI in sport.

Ubiquitin C-Terminal Hydrolase L1 (UCH-L1)

Six studies used UCH-L1 [42, 52, 55, 70, 83, 85] to investigate the effects of RSHI on athletes’ brain health (see Table 1 for details), with the median sample size of 34 (range 15 to 415) contact sport athletes. Three studies reported a significant increase in UCH-L1 levels acutely following RSHI exposure [42, 70, 85]. Two studies also assessed UCH-L1 concentrations in semi-acute and two in chronic settings. One of the semi-acute studies found a significant increase in UCH-L1 concentrations following a season of American football [42], whereas the majority of the samples were not quantifiable in the other study [52]. Neither of the studies assessing the chronic effects of RSHI found increased UCH-L1 levels [55, 83]. Therefore, UCH-L1 appears to be increased acutely but not chronically following RSHI exposure; however, the evidence thus far is limited.

Hormonal Studies

Nine studies investigated the effects of RSHI on the hormonal response (see Additional file 1: Table S7), with the median sample size of 22 (range 11 to 68) contact sport athletes. One case study reported the acute and semi-acute effects of RSHI on hormone levels in a kickboxer [113], and eight studies reported the chronic effects [100, 103, 104, 107, 111, 114,115,116]. Five studies that examined the chronic effects of RSHI in boxing and American football revealed growth hormone secretory deficiencies [103, 104, 114, 115], anti-hypothalamus and anti-pituitary antibodies presence [116], insulin-like growth factor 1 [103, 114] and adrenocorticotropic hormone [114, 115] deficiency, and hypogonadism [104]. RSHI exposure in soccer players revealed no long-term effects on hormonal responses [100, 111]. Overall, sustained exposure to RSHI appears to increase the risk of pituitary dysfunction in contact sport athletes.


This scoping review provides a broad overview of the currently available evidence on the effects of RSHI on biofluid marker levels. We identified 79 studies, with research in this field demonstrating exponential growth (Fig. 2). This review sheds light on a significant body of evidence not previously identified, i.e., two previous systematic reviews on the same topic identified just five relevant papers each [21, 22]. The discrepancy in the number of relevant articles identified in the current and prior reviews is perhaps caused by the latter either not focusing solely on biofluid markers, thus including fewer biomarker-specific keywords in their search strategy [21, 22], or focusing on specific study designs [21].

The findings of our review demonstrate that acute effects of RSHI have been studied most (n = 49), while the number of studies assessing biofluid marker levels following semi-acute (n = 23) and chronic (n = 26) RSHI exposure are similar. Our inclusion criteria allowed us to identify a large panel of biofluid markers linked to traumatic brain injury, such as axonal damage, compromised blood–brain-barrier integrity and neurodegeneration. Although there were several interesting candidate biomarkers with fewer than five studies available, making marker-specific conclusions was not feasible due to methodological differences such as sampling times. Therefore, this review focused on detecting patterns in the most studied biofluid markers.

S100B, an astrocyte-enriched Ca2 + -binding protein that helps regulate intracellular calcium concentrations [120], was the most extensively studied biomarker. However, its utility for the purpose of examining RSHI effects in contact sports is questionable due to its extracerebral presence (S100B is also present in other tissues such as chondrocytes, adipocytes, and bone marrow cells) [120]. Indeed, we noted significant increases in S100B in the control group or control condition of several studies included in this review where exercise was involved [64, 67, 69, 72, 74, 76]. This is unsurprising considering that previous evidence has demonstrated S100B increases in athletes participating in noncontact sports without RSHI [121]. Consequently, although S100B demonstrated a dose–response relationship with impact metrics, this marker may not be suited for assessing the effects of RSHI in a sporting setting due to also being affected by exercise alone. Based on our findings, S100B shows very limited, if any, utility in detecting RSHI-induced changes in semi-acute and chronic settings.

GFAP, a cytoskeletal protein almost exclusively present in astrocytes [122], demonstrated no effects in the majority (~ 67%) of the studies investigating the acute effects of RSHI. Previously, GFAP has been shown to differentiate mild brain injury (Glasgow Coma Scale score 13–15 with clear MRI scans) from healthy control data [24]. Semi-acute and chronic levels of GFAP did not appear to be affected by RSHI exposure.

The axonal injury marker NfL [30] is, perhaps, the most promising of all the studied markers in demonstrating elevated levels acutely following RSHI exposure. Importantly, its levels appear to increase in a dose–response manner [46, 47, 79, 94]. NfL also demonstrated some promise in evidencing the semi-acute effects of RSHI. In contrast, tau, the second most studied marker in RSHI research (and abundant in thin unmyelinated cortical interneurons [30]) yielded mixed findings across acute, semi-acute, and chronic settings. Biofluid marker concentrations are known to scale to the severity of brain injury [123], and as such, it is possible that some studies did not find significant effects because the quantity and severity of the RSHI did not result in injury, whereas some studies may simply have failed to detect changes in marker concentrations due to methodologies surrounding assays and sampling times.

The most frequently studied neuronal injury markers, NSE and UCH-L1, had limited numbers of studies of RSHI available, and no conclusions could be drawn.

Sampling Source and Time

The majority of the studies sampled biofluid markers from venous blood (n = 72), with only six studies assessing the concentrations in CSF and four in saliva. More studies sampling biomarkers from both blood and CSF are necessary to ensure that the changes in blood reflect changes in the central nervous system (CNS). This is particularly important for markers that are not specific to the CNS. Although the current research is not at a stage where blood or saliva samples can be reliably associated with brain alterations caused by RSHI exposure, the end goal in this field of research should be the identification of biofluid markers that can be sampled efficiently and non-invasively for the routine monitoring of athletes’ brain health.

In this review, we were unable to identify the most appropriate marker-specific sampling times following RSHI exposure. This was due to the mixed findings reported, the heterogeneity of the included studies, and the fact that most studies provided little, if any, justification surrounding sampling time choices. The time course of RSHI effects and how it relates to the changes in the levels of different biofluid markers is currently unclear. Critically, more research is needed, as discussed below.

Quality and Limitations of the Identified Studies

A further aim of this scoping review was to assess the quality of the available evidence and identify research gaps in order to guide future research. We identified limitations in the following three main categories: (1) lack of appropriate control of confounding variables, (2) lack of impact monitoring, and (3) representativeness of the sampled populations. Similar concerns have been highlighted before in the field of RSHI in general [21, 22, 124].

We found that only ~ 10% of the studies could be considered to have a low risk of bias and that the primary domain increasing the bias was controlling for confounding variables. Common confounding variables that were not controlled include prior concussions, concussions occurring during the study, and the effect of exercise. Furthermore, 27 studies (34%) did not employ a control condition or a control group. It is imperative that future research utilizes control groups, or conditions to control for the effect of exercise, to ensure that changes in biomarker concentrations are not driven by confounding variables.

Another important limitation of the current evidence was the lack of monitoring and quantification of RSHI exposure. Strikingly, around 40% of the studies did not quantify or estimate RSHI exposure. Moreover, only 12 studies employed accelerometers to document impact. The sports where accelerometers were utilized most in the context of RSHI were American football (n = 6) and soccer (n = 5). There were no studies measuring impact magnitude in boxing, despite it being the third most studied sport. The number of studies assuming, rather than measuring, the occurrence of RSHI is concerning, especially since without data on impact metrics it is not possible to examine the dose–response relationship between impact exposure and brain changes. Furthermore, only 15 studies (~ 19%) provided a definition for RSHI. Not characterizing RSHI is an issue, especially if investigators do not separate RHSI from concussive impacts in research.

The studied samples were not fully representative of the population of interest, especially in respect to sex and age, hampering the generalizability of the results. There was limited evidence documenting the effects of RSHI exposure in females using biofluid markers. The majority of the studies (n = 42) were carried out in a male-only cohort, whereas there were only two female-only studies. While there were 20 studies that used a mixed-sex approach, only 14 compared or acknowledged sex differences. Concerningly, sex was not specified in 15 studies. We also identified only three studies done in a juvenile-only cohort (~ 13–17-year-olds), with retired contact sport athletes also being understudied, as the majority of the studies assessing chronic effects of RSHI were conducted in active contact sport athletes.

Strengths and Limitations

The strengths of the current review are the adherence to an a priori-developed and published review protocol, following the PRISMA-ScR guidelines, and most importantly, the comprehensive search strategy used. The latter has reduced the risk of overlooking relevant research conducted in the field of RSHI and biofluid markers, and has enabled us to provide a full overview of the research done in this field from its inception until this review—an overview that was not available until now.

We acknowledge that this review has limitations. The generalizability of our findings is limited to sport-specific effects and may not be true for RSHI occurring in other settings (e.g., military, domestic abuse, etc.). Furthermore, concussion studies that employed a control group of contact sport athletes (where it was not clear whether RSHI had occurred) were not included in this review. As such, potentially relevant research may have been excluded from the current review; however, we believe that any such studies would have added little value for the purpose of this review due to the ambiguity surrounding the occurrence of RSHI.

Future Research

Our analysis showed that many of the studies included in this review are highly variable and present issues in the study design, quality, and analysis, resulting in biased reporting. This review demonstrated that most of the current research does not define RSHI or quantify impact exposure (Table 2); this prevents studies from drawing firm conclusions and consequently hinders the advancement of the field. Therefore, future studies should ensure that RSHI is clearly defined and distinguishable from concussive impacts. Furthermore, all future studies of RSHI should aim to quantify the impacts, for example, by using sensors.

One of the most common confounding variables identified in this review was the effect of exercise. Notably, S100B was found to be increased in the control groups/conditions of several studies included in this review where exercise was involved [64, 67, 69, 72, 74, 76]. Furthermore, physical exertion and its duration are known to affect serum levels of GFAP and UCH-L1 [125]. Therefore, future biofluid marker RSHI studies need to control for the effects of exercise.

Few studies included in this review were found to examine females and juveniles, while studies including both male and female athletes did not always consider the role of sex. The influence of sex on neurobiology and neurophysiology is largely recognized, and several lines of evidence confirm sex differences in biomarker levels that must be accounted for [126,127,128]. Therefore, future studies in RSHI and biofluid markers should consider sex differences. Age is also an important covariate that should be controlled. Indeed, studies of juvenile cohorts are limited, and a major knowledge gap remains with regard to how age influences biomarker levels.

One factor that can reduce the heterogeneity of the studies in the field could also be the way the methodological aspects of sampling are standardized and reported. The uncertainty around the best time to sample following RSHI is an urgent pre-analytical factor that needs to be resolved. Furthermore, methods of sampling blood biomarkers are subject to substantial variation with respect to blood collection, choice and preparation of serum or plasma, storage of samples, and the analytical platforms used [129]. Lack of standardization of such pre-analytical variables often makes it impossible to compare results from different laboratories, and potentially adds to noise within studies. In agreement with McDonald et al. [129], we observed that aspects of these processes were often inconsistently documented and note that addressing such variation remains a key issue for future work.

With regard to the current uncertainty about optimal sampling time following exposure to RSHI, marker-specific factors such as half-life should be considered. While it is presently unknown when to sample following RSHI, it may be possible to initially use the marker-specific temporal trends following concussion as a frame of reference. We note, however, that critical RSHI-specific information will rely on researching individual markers’ RSHI-specific response and temporal profile, where possible, sampling at multiple timepoints following RSHI exposure to define the RSHI-specific response and temporal profile of individual markers. Evidence from studies in TBI suggests that temporal profiles of biomarkers are important, and specifically that late biomarker elevation may signal progressive neurological disease [29]. Long-term longitudinal studies in RSHI are needed to address this issue.

There is a need for novel markers capable of providing insight into the pathobiology and pathogenetic mechanisms and demonstrating the link with neurodegeneration (e.g., CTE) [130]. The assessment of circulating levels of P-tau181 and P-tau217 [131], and markers reflecting changes in baseline cerebral physiology and metabolism [132, 133], would be instrumental for the accurate characterization of cerebral health and are therefore a critical avenue for future investigation. Both with regard to novel markers and established markers, we need to understand the mechanisms and understand the link with neurodegeneration. Multimodal studies have a critical role to play, however, in this review, we identified a limited number of studies using multiple methods to date. Therefore, it is recommended that future studies combine biofluid markers with other methods that can reveal the mechanisms of pathology following RSHI exposure, such as combining neuro-imaging and sensitive and informative measures of cognition and motor control [18], and that imaging methods are multi-modal (e.g., [134, 135]).


In this first review dedicated to systematically scoping the evidence of biofluid marker levels following RSHI exposure, a considerable number of studies were identified. Nevertheless, biofluid marker RSHI research was found to be in its early stages. Presently, the field is overwhelmingly heterogeneous, and the available studies suffer from specific methodological weaknesses. Through systematic scoping of the current evidence, however, we could determine specific ways in which the quality of future studies can be improved. Improving the quality of future research is necessary to assess the utility of under-explored markers as well as those markers that currently appear to show promise. In the meantime, despite the limitations and quality of the current evidence base, the fact that increased levels of brain injury markers were found in biofluids following RSHI exposure warrants caution over the safety of routine RSHI exposure.

Availability of Data and Materials

Extracted data are available at



Brain-derived neurotrophic factor


Central nervous system CSF: cerebrospinal fluid


Chronic traumatic encephalopathy


Extracellular vesicles


Glial fibrillary acidic protein




Neurofilament light


Neuron-specific enolase


Population, exposure, comparator, outcomes and study design


Preferred reporting items for systematic reviews and meta-analyses extension for scoping reviews


Phosphorylated tau


Risk of bias in non-randomized studies of interventions


Repetitive subconcussive head impacts


S100 calcium-binding protein beta


Subconcussion-specific tool


Traumatic brain injury


Ubiquitin C-terminal hydrolase L1


  1. Ling H, Morris HR, Neal JW, Lees AJ, Hardy J, Holton JL, et al. Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players. Acta Neuropathol. 2017;133:337–52.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Mackay DF, Russell ER, Stewart K, MacLean JA, Pell JP, Stewart W. Neurodegenerative disease mortality among former professional soccer players. N Engl J Med. 2019;381:1801–8.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Omalu BI, DeKosky ST, Minster RL, Kamboh MI, Hamilton RL, Wecht CH. Chronic traumatic encephalopathy in a national football league player. Neurosurgery. 2005;57:128–33.

    Article  PubMed  Google Scholar 

  4. Omalu BI, DeKosky ST, Hamilton RL, Minster RL, Kamboh MI, Shakir AM, et al. Chronic traumatic encephalopathy in a national football league player: part II. Neurosurgery. 2006;59:1086–92.

    Article  PubMed  Google Scholar 

  5. Chiò A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472–6.

    Article  PubMed  Google Scholar 

  6. Wilson L, Stewart W, Dams-O’Connor K, Diaz-Arrastia R, Horton L, Menon DK, et al. The chronic and evolving neurological consequences of traumatic brain injury. Lancet Neurol. 2017;16:813–25.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ueda P, Pasternak B, Lim C-E, Neovius M, Kader M, Forssblad M, et al. Neurodegenerative disease among male elite football (soccer) players in Sweden: a cohort study. Lancet Public Heal. 2023;256:65.

    Google Scholar 

  8. Lehman EJ, Hein MJ, Baron SL, Gersic CM. Neurodegenerative causes of death among retired National Football League players. Neurology [Internet]. 2012;79:1970–4.

    Article  PubMed  Google Scholar 

  9. Russell ER, Mackay DF, Lyall D, Stewart K, MacLean JA, Robson J, et al. Neurodegenerative disease risk among former international rugby union players. J Neurol Neurosurg Psychiatry. 2022;93:1262.

    Article  PubMed  Google Scholar 

  10. Förstl H, Haass C, Hemmer B, Meyer B, Halle M. Boxing-acute complications and late sequelae: from concussion to dementia. Dtsch Arztebl Int. 2010;107:835–9.

    PubMed  PubMed Central  Google Scholar 

  11. Jordan BD, Jahre C, Hauser WA, Zimmerman RD, Zarrelli M, Lipsitz EC, et al. CT of 338 active professional boxers. Radiol Radiol Soc N Am. 1992;185:509–12.

    CAS  Google Scholar 

  12. Jordan BD. Chronic traumatic brain injury associated with boxing. Semin Neurol U S. 2000;20:179–85.

    Article  CAS  Google Scholar 

  13. Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16:987–1048.

    Article  PubMed  Google Scholar 

  14. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020.

  15. Stein TD, Alvarez VE, McKee AC. Concussion in chronic traumatic encephalopathy. Curr Pain Headache Rep. 2015;19:47.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Smith DH, Johnson VE, Trojanowski JQ, Stewart W. Chronic traumatic encephalopathy — confusion and controversies. Nat Rev Neurol 2019.

  17. Montenigro PH, Alosco ML, Martin BM, Daneshvar DH, Mez J, Chaisson CE, et al. Cumulative head impact exposure predicts later-life depression, apathy, executive dysfunction, and cognitive impairment in former high school and college football players. J Neurotrauma. 2017;34:328–40.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ntikas M, Binkofski F, Shah NJ, Ietswaart M. Repeated sub-concussive impacts and the negative effects of contact sports on cognition and brain integrity. Int J Environ Res Public Health. 2022;19.

  19. Lember L-M, Ntikas M, Mondello S, Wilson L, Hunter A, Di Virgilio T, et al. Effects of sport-related repetitive subconcussive head impacts on biofluid markers: a scoping review protocol. BMJ Open. 2021;11:e046452.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Myer GD, Barber Foss K, Thomas S, Galloway R, Dicesare CA, Dudley J, et al. Altered brain microstructure in association with repetitive subconcussive head impacts and the potential protective effect of jugular vein compression: A longitudinal study of female soccer athletes. Br J Sports Med. 2019;53:1539–51.

    Article  PubMed  Google Scholar 

  21. Walter AE, Wilkes JR, Arnett PA, Miller SJ, Sebastianelli W, Seidenberg P, et al. The accumulation of subconcussive impacts on cognitive, imaging, and biomarker outcomes in child and college-aged athletes: a systematic review. Brain Imaging Behav. 2022;16:503–17.

    Article  PubMed  Google Scholar 

  22. Mainwaring L, Ferdinand Pennock KM, Mylabathula S, Alavie BZ. Subconcussive head impacts in sport: a systematic review of the evidence. Int J Psychophysiol. 2018;132:39–54.

    Article  PubMed  Google Scholar 

  23. Helmrich IRAR, Czeiter E, Amrein K, Büki A, Lingsma HF, Menon DK, et al. Incremental prognostic value of acute serum biomarkers for functional outcome after traumatic brain injury (CENTER-TBI): an observational cohort study. Lancet Neurol. 2022;21:792–802.

    Article  CAS  PubMed  Google Scholar 

  24. Yue JK, Yuh EL, Korley FK, Winkler EA, Sun X, Puffer RC, et al. Association between plasma GFAP concentrations and MRI abnormalities in patients with CT-negative traumatic brain injury in the TRACK-TBI cohort: a prospective multicentre study. Lancet Neurol. 2019;18.

  25. Czeiter E, Amrein K, Gravesteijn BY, Lecky F, Menon DK, Mondello S, et al. Blood biomarkers on admission in acute traumatic brain injury: relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine. 2020;56:1–11.

    Article  Google Scholar 

  26. Review ALS, Mondello S, Sorinola A, Synnot A, Donoghue E, Wang KKW, et al. Blood-based protein biomarkers for the management of traumatic brain injuries in adults presenting to emergency departments with mild. Brain Inj. 2021;1106:1086–106.

    Google Scholar 

  27. Korley FK, Jain S, Sun X, Puccio AM, Yue JK, Gardner RC, et al. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study. Lancet Neurol. 2022;21:803–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Mondello S, Shear DA, Bramlett HM, Dixon CE, Schmid KE, Dietrich WD, et al. Insight into pre-clinical models of traumatic brain injury using circulating brain damage biomarkers: operation brain trauma therapy. J Neurotrauma. 2016;33:595–605.

    Article  PubMed  Google Scholar 

  29. Newcombe VFJ, Ashton NJ, Posti JP, Glocker B, Manktelow A, Chatfield DA, et al. Post-acute blood biomarkers and disease progression in traumatic brain injury. Brain. 2022;145:2064–76.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol. 2013;9:201–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Mondello S, Jeromin A, Buki A, Bullock R, Czeiter E, Kovacs N, et al. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J Neurotrauma. 2012;29:1096–104.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Halford J, Shen S, Itamura K, Levine J, Chong AC, Czerwieniec G, et al. New astroglial injury-defined biomarkers for neurotrauma assessment. J Cereb Blood Flow Metab. 2017;37.

  33. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med Am Colle Phys; 2018. p. 467–73.

  34. Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Comper P, Hutchison M, Magrys S, Mainwaring L, Richards D. Evaluating the methodological quality of sports neuropsychology concussion research: a systematic review. Brain Inj. 2010;24:1257–71.

    Article  PubMed  Google Scholar 

  36. McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods.

  37. Brayne CEG, Calloway SP, Dow L, Thompson RJ. Blood creatine kinase isoenzyme Bb in boxers. Lancet. 1982;320:1308–9.

    Article  Google Scholar 

  38. Stålnacke BM, Ohlsson A, Tegner Y, Sojka P. Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game. Br J Sports Med. 2006;40:313–6.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Antonio J, Cabrera D, Knafo S, Thomas J, Peacock C, Tartar J. Neurofilament light (NFL) in division II female soccer players: a potential biomarker for brain trauma. J Exerc Physiol Online. 2021;24:1–6.

    Google Scholar 

  40. Mussack T, Dvorak J, Graf-Baumann T, Jochum M. Serum S-100B protein levels in young amateur soccer players after controlled heading and normal exercise. Eur J Med Res. 2003;8:457–64.

    CAS  PubMed  Google Scholar 

  41. Zonner SW, Ejima K, Bevilacqua ZW, Huibregtse ME, Charleston C, Fulgar C, et al. Association of increased serum S100B levels with high school football subconcussive head impacts. Front Neurol. 2019;10:1–10.

    Article  Google Scholar 

  42. Joseph JR, Swallow JS, Willsey K, Lapointe AP, Khalatbari S, Korley FK, et al. Elevated markers of brain injury as a result of clinically asymptomatic high-acceleration head impacts in high-school football athletes. J Neurosurg. 2019;130:1642–8.

    Article  Google Scholar 

  43. Alosco ML, Tripodis Y, Fritts NG, Heslegrave A, Baugh CM, Conneely S, et al. Cerebrospinal fluid tau, Aβ and sTREM2 in former national football league players: modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alzheimer’s Dement. 2018;14:1159–70.

    Article  Google Scholar 

  44. Muraoka S, Jedrychowski MP, Tatebe H, DeLeo AM, Ikezu S, Tokuda T, et al. Proteomic profiling of extracellular vesicles isolated from cerebrospinal fluid of former national football league players at risk for chronic traumatic encephalopathy. Front Neurosci. 2019;13:1–12.

    Article  Google Scholar 

  45. Neselius S, Zetterberg H, Blennow K, Marcusson J, Brisby H. Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers. PLoS ONE. 2013;8:1–5.

    Article  Google Scholar 

  46. Neselius S, Brisby H, Theodorsson A, Blennow K, Zetterberg H, Marcusson J. Csf-biomarkers in olympic boxing: diagnosis and effects of repetitive head trauma. PLoS ONE. 2012;7:1–8.

    Article  Google Scholar 

  47. Zetterberg H, Hietala MA, Jonsson M, Andreasen N, Styrud E, Karlsson I, et al. Neurochemical aftermath of amateur boxing. Arch Neurol. 2006;63:1277–80.

    Article  PubMed  Google Scholar 

  48. Zetterberg H, Jonsson M, Rasulzada A, Popa C, Styrud E, Hietala MA, et al. No neurochemical evidence for brain injury caused by heading in soccer. Br J Sports Med. 2007;41:574–7.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Hicks SD, Onks C, Kim RY, Zhen KJ, Loeffert J, Loeffert AC, et al. Refinement of saliva microRNA biomarkers for sports-related concussion. J Sport Heal Sci. 2021.

  50. Matuk R, Pereira M, Baird J, Dooner M, Cheng Y, Wen S, et al. The role of salivary vesicles as a potential inflammatory biomarker to detect traumatic brain injury in mixed martial artists. Sci Rep. 2021;11:8186.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Pin E, Petricoin EF, Cortes N, Bowman TG, Andersson E, Uhlén M, et al. Immunoglobulin a autoreactivity toward brain enriched and apoptosis-regulating proteins in saliva of athletes after acute concussion and subconcussive impacts. J Neurotrauma. 2021;38:2373–83.

    Article  PubMed  Google Scholar 

  52. Soriano S, Curry K, Sadrameli SS, Wang Q, Nute M, Reeves E, et al. Alterations to the gut microbiome after sport-related concussion in a collegiate football players cohort: a pilot study. Brain Behav Immun Heal. 2022;21:100438.

    Article  CAS  Google Scholar 

  53. Symons GF, Clough M, O’Brien WT, Ernest J, Salberg S, Costello D, et al. Shortened telomeres and serum protein biomarker abnormalities in collision sport athletes regardless of concussion history and sex. J Concussion. 2020;4:205970022097560.

    Article  Google Scholar 

  54. Arslan F, Büyükyazi G, Ulman C, Taneli F, Gözlükaya F, Çalkan M. Examining acute changes in some serum biochemical markers of brain tissue damage after free and Greco-Roman style wrestling. Turkish J Biochem. 2010;35:307–12.

    CAS  Google Scholar 

  55. Asken BM, Bauer RM, Dekosky ST, Houck ZM, Moreno CC, Jaffee MS, et al. Article concussion basics II baseline serum biomarkers, head impact exposure, and clinical measures. Neurology. 2018;91:E2123–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Bouvier D, Duret T, Abbot M, Stiernon T, Pereira B, Coste A, et al. Utility of S100B serum level for the determination of concussion in male rugby players. Sport Med. 2017;47:781–9.

    Article  Google Scholar 

  57. Battista APD, Rhind SG, Richards D, Churchill N, Baker AJ, Hutchison MG. Altered blood biomarker profiles in athletes with a history of repetitive head impacts. Toronto: University of Toronto; 2016. p. 11.

    Google Scholar 

  58. Dorminy M, Hoogeveen A, Tierney RT, Higgins M, McDevitt JK, Kretzschmar J. Effect of soccer heading ball speed on S100B, sideline concussion assessments and head impact kinematics. Brain Inj. 2015;29:1158–64.

    Article  PubMed  Google Scholar 

  59. Graham MR, Myers T, Evans P, Davies B, Cooper SM, Bhattacharya K, et al. Direct hits to the head during amateur boxing is associated with a rise in serum biomarkers for brain injury. Int J Immunopathol Pharmacol. 2011;24:119–25.

    Article  CAS  PubMed  Google Scholar 

  60. Graham MR, Pates J, Davies B, Cooper SM, Bhattacharya K, Evans PJ, et al. Should an increase in cerebral neurochemicals following head kicks in full contact karate influence return to play? Int J Immunopathol Pharmacol. 2015;28:539–46.

    Article  CAS  PubMed  Google Scholar 

  61. Hoffman JR, Ostfeld I, Zamir A, Amedi R, Fonville TR, Horstemeyer MF, et al. Examination of cognitive function, neurotrophin concentrations, and both brain and systemic inflammatory markers following a simulated game of American Football. J Strength Cond Res. 2022;36:686–94.

    Article  PubMed  Google Scholar 

  62. Huibregtse ME, Nowak MK, Kim JE, Kalbfell RM, Koppineni A, Ejima K, et al. Does acute soccer heading cause an increase in plasma S100B? A randomized controlled trial. PLoS ONE. 2020;15:e0239507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Kawata K. Subconcussive head impact effect on plasma expression of S100-beta and PINCH proteins in collegiate football players. Temple University; 2016.

    Google Scholar 

  64. Kawata K, Rubin LH, Takahagi M, Lee JH, Sim T, Szwanki V, et al. Subconcussive impact-dependent increase in plasma S100β levels in collegiate football players. J Neurotrauma. 2017;34:2254–60.

    Article  PubMed  Google Scholar 

  65. Marchi N, Bazarian JJ, Puvenna V, Janigro M, Ghosh C, Zhong J, et al. Consequences of repeated blood-brain barrier disruption in football players. PLoS One. 2013;8.

  66. Neselius S, Zetterberg H, Blennow K, Randall J, Wilson D, Marcusson J, et al. Olympic boxing is associated with elevated levels of the neuronal protein tau in plasma. Brain Inj. 2013;27:425–33.

    Article  PubMed  Google Scholar 

  67. O’Connell B, Wilson F, Boyle N, O’Dwyer T, Denvir K, Farrell G, et al. Effects of match play and training on circulating S100B concentration in professional rugby players. Brain Inj. 2018;32:1811–6.

    Article  PubMed  Google Scholar 

  68. O’Keeffe E, Kelly E, Liu Y, Giordano C, Wallace E, Hynes M, et al. Dynamic blood-brain barrier regulation in mild traumatic brain injury. J Neurotrauma. 2020;37:347–56.

    Article  PubMed  Google Scholar 

  69. Otto M, Holthusen S, Bahn E, Sohnchen N, Wiltfang J, Geese R, et al. Boxing and running lead to a rise in serum levels of S-100B protein. Int J Sports Med. 2000;21:551–5.

    Article  CAS  PubMed  Google Scholar 

  70. Puvenna V, Brennan C, Shaw G, Yang C, Marchi N, Bazarian JJ, et al. Significance of ubiquitin carboxy-terminal hydrolase L1 elevations in athletes after sub-concussive head hits. PLoS ONE. 2014;9:1–9.

    Article  Google Scholar 

  71. Rogatzki MJ, Soja SE, McCabe CA, Breckenridge RE, White JL, Baker JS. Biomarkers of brain injury following an American football game: a pilot study. Int J Immunopathol Pharmacol. 2016;29:450–7.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Rogatzki MJ, Keuler SA, Harris AE, Ringgenberg SW, Breckenridge RE, White JL, et al. Response of protein S100B to playing American football, lifting weights, and treadmill running. Scand J Med Sci Sport. 2018;28:2505–14.

    Article  Google Scholar 

  73. Stålnacke BM, Sojka P. Repeatedly heading a soccer ball does not increase serum levels of S-100B, a biochemical marker of brain tissue damage: an experimental Study. Biomark Insights. 2008;2008:87–91.

    Google Scholar 

  74. Stålnacke BM, Tegner Y, Sojka P. Playing ice hockey and basketball increases serum levels of S-100B in elite players: a pilot study. Clin J Sport Med United States. 2003;13:292–302.

    Article  Google Scholar 

  75. Stålnacke BM, Tegner Y, Sojka P. Playing soccer increases serum concentrations of the biochemical markers of brain damage S-100B and neuron-specific enolase in elite players: a pilot study. Brain Inj. 2004;18:899–909.

    Article  PubMed  Google Scholar 

  76. Straume-Naesheim TM, Andersen TE, Jochum M, Dvorak J, Bahr R. Minor head trauma in soccer and serum levels of S100B. Neurosurgery. 2008;62:1297–305.

    Article  PubMed  Google Scholar 

  77. Zetterberg H, Tanriverdi F, Unluhizarci K, Selcuklu A, Kelestimur F, Blennow K. Sustained release of neuron-specific enolase to serum in amateur boxers. Brain Inj. 2009;23:723–6.

    Article  PubMed  Google Scholar 

  78. Alosco ML, Tripodis Y, Jarnagin J, Baugh CM, Martin B, Chaisson CE, et al. Repetitive head impact exposure and later-life plasma total tau in former National Football League players. Alzheimer’s Dement Diagnos Assess Dis Monit. 2017;7:33–40.

    Google Scholar 

  79. Bernick C, Zetterberg H, Shan G, Banks S, Blennow K. Longitudinal performance of plasma neurofilament light and tau in professional fighters: the professional fighters brain health study. J Neurotrauma. 2018;35:2351–6.

    Article  PubMed  Google Scholar 

  80. Battista APD, Rhind SG, Richards D, Churchill N, Baker AJ, Hutchison MG. Altered blood biomarker profiles in athletes with a history of repetitive head impacts. PLoS ONE. 2016;11:1–14.

    Google Scholar 

  81. Kawata K, Rubin LH, Wesley L, Lee JH, Sim T, Takahagi M, et al. Acute changes in plasma total tau levels are independent of subconcussive head impacts in college football players. J Neurotrauma. 2018;35:260–6.

    Article  PubMed  Google Scholar 

  82. Kawata K, Mitsuhashi M, Aldret R. A preliminary report on brain-derived extracellular vesicle as novel blood biomarkers for sport-related concussions. Front Neurol. 2018;9:1–11.

    Article  Google Scholar 

  83. Major BP, McDonald SJ, O’Brien WT, Symons GF, Clough M, Costello D, et al. Serum Protein Biomarker Findings Reflective of Oxidative Stress and Vascular Abnormalities in Male, but Not Female, Collision Sport Athletes. Front Neurol; 2020;11.

  84. Muraoka S, DeLeo AM, Yang Z, Tatebe H, Yukawa-Takamatsu K, Ikezu S, et al. Proteomic profiling of extracellular vesicles separated from plasma of former National Football League players at risk for chronic traumatic encephalopathy. Aging Dis. 2021;12:1363–75.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Nowak MK, Ejima K, Quinn PD, Bazarian JJ, Mickleborough TD, Harezlak J, et al. ADHD may associate with reduced tolerance to acute subconcussive head impacts: a pilot case-control intervention study. J Atten Disord [Internet]. 2022;26:125–39.

    Article  PubMed  Google Scholar 

  86. Oliver JM, Jones MT, Anzalone AJ, Kirk KM, Gable DA, Repshas JT, et al. A season of American football is not associated with changes in plasma tau. J Neurotrauma. 2017;34:3295–300.

    Article  PubMed  Google Scholar 

  87. Oliver JM, Anzalone AJ, Stone JD, Turner SM, Blueitt D, Garrison JC, et al. Fluctuations in blood biomarkers of head trauma in NCAA football athletes over the course of a season. J Neurosurg. 2019;130:1655–62.

    Article  Google Scholar 

  88. Sandmo SB, Filipcik P, Cente M, Hanes J, Andersen TE, Straume-Naesheim TM, et al. Neurofilament light and tau in serum after head-impact exposure in soccer. Brain Inj. 2020;34:602–9.

    Article  PubMed  Google Scholar 

  89. Stern RA, Tripodis Y, Baugh CM, Fritts NG, Martin BM, Chaisson C, et al. Preliminary study of plasma exosomal tau as a potential biomarker for chronic traumatic encephalopathy. J Alzheimer’s Dis. 2016;51:1099–109.

    Article  CAS  Google Scholar 

  90. Wallace C, Smirl JD, Zetterberg H, Blennow K, Bryk K, Burma J, et al. Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics. BMJ Open Sport Exerc Med. 2018;4:1–5.

    Article  Google Scholar 

  91. Austin K, Lee BJ, Flood TR, Toombs J, Borisova M, Lauder M, et al. Serum neurofilament light concentration does not increase following exposure to low velocity football heading. Sci Med Footb. 2021;5:188–94.

    Article  PubMed  Google Scholar 

  92. Heileson JL, Anzalone AJ, Carbuhn AF, Askow AT, Stone JD, Turner SM, et al. The effect of omega-3 fatty acids on a biomarker of head trauma in NCAA football athletes: a multi-site, non-randomized study. J Int Soc Sports Nutr. 2021;18:1–13.

    Article  Google Scholar 

  93. Oliver JM, Jones MT, Kirk KM, Gable DA, Repshas JT, Johnson TA, et al. Serum neurofilament light in American football athletes over the course of a season. J Neurotrauma. 2016;33:1784–9.

    Article  PubMed  Google Scholar 

  94. Rubin LH, Tierney R, Kawata K, Wesley L, Lee JH, Blennow K, et al. NFL blood levels are moderated by subconcussive impacts in a cohort of college football players. Brain Inj. 2019;33:456–62.

    Article  PubMed  Google Scholar 

  95. Shahim P, Zetterberg H, Tegner Y, Blennow K. Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. Neurology. 2017;88:1788–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Wirsching A, Chen Z, Bevilacqua ZW, Huibregtse ME, Kawata K. Association of acute increase in plasma neurofilament light with repetitive subconcussive head impacts: a pilot randomized control trial. J Neurotrauma. 2019;36:548–53.

    Article  PubMed  Google Scholar 

  97. Horner EB, Lee TC, Tipton KF, O’Brien M, Phillips JP. Creatine kinase and neuron-specific enolase: serum markers of cell damage in the central nervous system in boxers. Clin J Sport Med. 1993;3:144–8.

    Article  Google Scholar 

  98. Bamaç B, Tamer GS, Colak T, Colak E, Seyrek E, Duman C, et al. Effects of repeatedly heading a soccer ball on serum levels of two neurotrophic factors of brain tissue, BDNF and NGF, in professional soccer players. Biol Sport. 2011;28:177–81.

    Article  Google Scholar 

  99. Oztasyonar Y. Interaction between different sports branches such as taekwondo, box, athletes and serum brain derived neurotrophic factor levels. J Sports Med Phys Fitness. 2017;57:457–60.

    Article  PubMed  Google Scholar 

  100. Akkurt S, Tanriverdi F, Kalay N, Karaca ZCO, Unluhizarci K, Sucan S, et al. Investigation of pituitary dysfunction in retired professional soccer players. Rev Bras Med do Esporte. 2020;26:503–7.

    Article  Google Scholar 

  101. Alosco ML, Tripodis Y, Jarnagin J, Baugh CM, Martin B, Chaisson CE, et al. Repetitive head impact exposure and later-life plasma total tau in former National Football League players. Alzheimer’s Dement Diagnosis Assess Dis Monit. 2017;7:33–40.

    Google Scholar 

  102. Huibregtse ME, Ejima K, Chen Z, Kalbfell RM, Koppineni A, Kawata K. Acute time-course changes in CCL11, CCL2, and IL-10 levels after controlled subconcussive head impacts: a pilot randomized clinical trial. J Head Trauma Rehabil. 2020;35:308–16.

    Article  PubMed  Google Scholar 

  103. Kelestimur F, Tanriverdi F, Atmaca H, KUnluhizarci, Selcuklu A, Casanueva FF. Boxing as a sport activity associated with isolated GH deficiency. J Endocrinol Invest. 2004;27.

  104. Kelly DF, Chaloner C, Evans D, Mathews A, Cohan P, Wang C, et al. Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study. J Neurotrauma. 2014;31:1161–71.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Meier TB, Savitz J, Singh R, Teague TK, Bellgowan PSF. Smaller dentate gyrus and CA2 and CA3 volumes are associated with kynurenine metabolites in collegiate football athletes. J Neurotrauma. 2016;33:1349–57.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Muñoz ER, Caccese JB, Wilson BE, Shuler KT, Santos FV, Cabán CT, et al. Effects of purposeful soccer heading on circulating small extracellular vesicle concentration and cargo. J Sport Heal Sci. 2021;10:122–30.

    Article  Google Scholar 

  107. Obmiński Z, Hübner-Wožniak E, Stanisław Ł. Hormonal and metabolic blood status in boxers after a 3-round match. Polish J Sport Tour. 2009;16:221–4.

    Google Scholar 

  108. O’Brien WT, Symons GF, Bain J, Major BP, Costello DM, Sun M, et al. Elevated serum interleukin-1β levels in male, but not female, collision sport athletes with a concussion history. J Neurotrauma [Internet]. 2021;38:1350–7.

    Article  PubMed  Google Scholar 

  109. Owens TS, Calverley TA, Stacey BS, Iannatelli A, Venables L, Rose G, et al. Contact events in rugby union and the link to reduced cognition: evidence for impaired redox-regulation of cerebrovascular function. Exp Physiol. 2021;106:1971–80.

    Article  CAS  PubMed  Google Scholar 

  110. Papa L, Slobounov SM, Breiter HC, Walter A, Bream T, Seidenberg P, et al. Elevations in MicroRNA biomarkers in serum are associated with measures of concussion, neurocognitive function, and subconcussive trauma over a single national collegiate athletic association division I season in collegiate football players. J Neurotrauma. 2019;36:1343–51.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Roser P, Wehrhahn T, Krogmann H, Riedel N, Marshall RP, Gille J, et al. Somatotrope pituitary function in professional soccer players. Exp Clin Endocrinol Diabetes. 2018;126:306–8.

    Article  CAS  PubMed  Google Scholar 

  112. Sandmo SB, Matyasova K, Filipcik P, Cente M, Koerte IK, Pasternak O, et al. Changes in circulating microRNAs following head impacts in soccer. Brain Inj. 2022;36:560–71.

    Article  PubMed  Google Scholar 

  113. Tanriverdi F, Unluhizarci K, Selcuklu A, Casanueva FF, Kelestimur F. Transient hypogonadotropic hypogonadism in an amateur kickboxer after head trauma. J Endocrinol Invest. 2007;30:150–2.

    Article  CAS  PubMed  Google Scholar 

  114. Tanriverdi F, Unluhizarci K, Coksevim B, Selcuklu A, Casanueva FF, Kelestimur F. Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism. Clin Endocrinol. 2007;66:360–6.

    Article  Google Scholar 

  115. Tanriverdi F, Unluhizarci K, Kocyigit I, Tuna IS, Karaca Z, Durak AC, et al. Brief communication: Pituitary volume and function in competing and retired male boxers. Ann Intern Med. 2008;148:827–31.

    Article  PubMed  Google Scholar 

  116. Tanriverdi F, De Bellis A, Battaglia M, Bellastella G, Bizzarro A, Sinisi AA, et al. Investigation of antihypothalamus and antipituitary antibodies in amateur boxers: Is chronic repetitive head trauma-induced pituitary dysfunction associated with autoimmunity? Eur J Endocrinol. 2010;162:861–7.

    Article  CAS  PubMed  Google Scholar 

  117. Vike NL, Bari S, Stetsiv K, Talavage TM, Nauman EA, Papa L, et al. Metabolomic response to collegiate football participation: pre- and post-season analysis. Sci Rep. 2022;12:3091.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Huibregtse ME, Nowak MK, Kim JE, Kalbfell RM, Koppineni A, Ejima K, et al. Does acute soccer heading cause an increase in plasma S100B? A randomized controlled trial. PLoS ONE. 2020;15:1–15.

    Article  Google Scholar 

  119. Bailey AM, McMurry TL, Cormier JM, Funk JR, Crandall JR, Mack CD, et al. Comparison of laboratory and on-field performance of american football helmets. Ann Biomed Eng. 2020;48:2531–41.

    Article  PubMed  Google Scholar 

  120. Azar S, Hasan A, Younes R, Najdi F, Baki L, Ghazale H, et al. Biofluid proteomics and biomarkers in traumatic brain injury. Methods Mol Biol. 2017.

  121. Hasselblatt M, Mooren FC, Von Ahsen N, Keyvani K, Fromme A, Schwarze-Eicker K, et al. Serum S100β increases in marathon runners reflect extracranial release rather than glial damage. Neurology. 2004;62.

  122. Petzold A. Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease. Brain Res. 2015.

  123. Whitehouse DP, Vile AR, Adatia K, Herlekar R, Roy AS, Mondello S, et al. Blood Biomarkers and Structural Imaging Correlations Post-Traumatic Brain Injury: A Systematic Review. Neurosurgery. 2022;90.

  124. Stephen SJ, Hasman L, Goldenberg M, Merchant-Borna K, Kawata K, Mannix R, et al. Short-term neurologic manifestations of repetitive head impacts among athletes: a scoping review. J Head Trauma Rehabil. 2022;37:318–25.

    Article  PubMed  Google Scholar 

  125. Bazarian JJ, Abar B, Merchant-Borna K, Pham DL, Rozen E, Mannix R, et al. Effects of physical exertion on early changes in blood-based brain biomarkers: implications for the acute point of care diagnosis of concussion. J Neurotrauma. 2022;

  126. Koerte IK, Schultz V, Sydnor VJ, Howell DR, Guenette JP, Dennis E, et al. Sex-related differences in the effects of sports-related concussion: a review. J Neuroimaging. 2020.

  127. Mondello S, Guedes VA, Lai C, Jeromin A, Bazarian JJ, Gill JM. Sex differences in circulating T-Tau trajectories after sports-concussion and correlation with outcome. Front Neurol. 2020;11:1–8.

    Article  Google Scholar 

  128. Asken BM, Bauer RM, DeKosky ST, Houck ZM, Moreno CC, Jaffee MS, et al. Concussion biomarkers assessed in collegiate student-athletes (BASICS) I. Neurology. 2018;91:e2109.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Mcdonald SJ, Shultz SR, Agoston DV. The known unknowns: an overview of the state of blood-based protein biomarkers of mild traumatic brain injury. J Neurotrauma. 2021;38:2652–66.

    Article  PubMed  Google Scholar 

  130. Alosco ML, Stern RA. The long-term consequences of repetitive head impacts: chronic traumatic encephalopathy. Handb Clin Neurol Elsevier. 2019;167:337–55.

    Article  Google Scholar 

  131. Asken BM, Tanner JA, Vandevrede L, Mantyh WG, Casaletto KB, Staffaroni AM, et al. Plasma P-tau181 and P-tau217 in patients with traumatic encephalopathy syndrome with and without evidence of Alzheimer disease pathology. Neurology. 2022;99.

  132. Peng W, Kobeissy F, Mondello S, Barsa C, Mechref Y. MS-based glycomics: An analytical tool to assess nervous system diseases. Front Neurosci. 2022.

  133. Mondello S, Sandner V, Goli M, Czeiter E, Amrein K, Kochanek PM, et al. Exploring serum glycome patterns after moderate to severe traumatic brain injury: A prospective pilot study. eClinicalMedicine. 2022;50.

  134. Koerte IK, Bahr R, Filipcik P, Gooijers J, Leemans A, Lin AP, et al. REPIMPACT - a prospective longitudinal multisite study on the effects of repetitive head impacts in youth soccer. Brain Imaging Behav. 2022;16:492–502.

    Article  PubMed  Google Scholar 

  135. Champagne AA, Coverdale NS, Germuska M, Bhogal AA, Cook DJ. Changes in volumetric and metabolic parameters relate to differences in exposure to sub-concussive head impacts. J Cereb Blood Flow Metab. 2020;40.

Download references


Not applicable.


This review was supported by the University of Stirling (no grant number applies). L.W. also received support as part of Framework 7 programme of the European Union (CENTER-TBI, Grant number: 602150–2). S.M. received research support from the Italian Ministry of Health (GR-2013–02354960).

Author information

Authors and Affiliations



L-ML and MN designed the review methodology which was reviewed and approved by MI, SM, LW, TDV and AH. L-ML and MN contributed equally to reviewing the literature, extracting the data and performing the analysis. MN, L-ML, SM and MI drafted the manuscript. L-ML, MN, SM, LW, TDV, AH, FK, YM, DID and MI reviewed and approved the final manuscript.

Corresponding author

Correspondence to Magdalena Ietswaart.

Ethics declarations

Ethics Approval and Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Competing interests

None of the authors have any competing interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Supplementary Materials.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lember, LM., Ntikas, M., Mondello, S. et al. The Use of Biofluid Markers to Evaluate the Consequences of Sport-Related Subconcussive Head Impact Exposure: A Scoping Review. Sports Med - Open 10, 12 (2024).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: